Leder Susanne, Czajkowska Hanna, Maenz Barbara, De Graaf Katrin, Barthel Andreas, Joost Hans-Georg, Becker Walter
Institut für Pharmakologie und Toxikologie, Medizinische Fakultät der RWTH Aachen, Wendlingweg 2, Germany.
Biochem J. 2003 Jun 15;372(Pt 3):881-8. doi: 10.1042/BJ20030182.
The dual specificity tyrosine phosphorylated and regulated kinase (DYRK) family of protein kinases is a group of evolutionarily conserved protein kinases that have been characterized as regulators of growth and development in mammals, Drosophila and lower eukaryotes. In the present study, we have characterized three splicing variants of DYRK1B (DYRK1B-p65, DYRK1B-p69 and DYRK1B-p75) with different expression patterns and enzymic activities. DYRK1B-p65 and DYRK1B-p69 exhibited similar, but not identical, patterns of expression in mouse tissues, with the highest protein levels found in the spleen, lung, brain, bladder, stomach and testis. In contrast, DYRK1B-p75 was detected specifically in skeletal muscles, in the neuronal cell line GT1-7 and also in differentiated, adipocyte-like 3T3-L1 cells, but not in undifferentiated 3T3-L1 preadipocytes. A comparison of the mouse and human Dyrk1b genomic and cDNA sequences defined the alternative splicing events that produce the variants of DYRK1B. In DYRK1B-p75, transcription starts with exon 1B instead of exon 1A, generating a new translation start, which extends the open reading frame by 60 codons. This gene structure suggests that alternative promoters direct the expression of DYRK1B-p69 and DYRK1B-p75. Both splicing variants exhibited kinase activity in vitro and contained phosphotyrosine when expressed in COS-7 cells. Owing to differential recognition of the 3'-splice site in exon 9, DYRK1B-p65 differs from DYRK1B-p69 by the absence of 40 amino acids within the catalytic domain. DYRK1B-p65 lacked kinase activity in vitro and did not contain phosphotyrosine. DYRK1B-p69 and DYRK1B-p75 stimulated reporter gene activity driven by the f or kh ead in r habdosarcoma (FKHR)-dependent glucose-6-phosphatase promoter more strongly when compared with DYRK1B-p65, indicating that the DYRK1B splicing variants exhibit functional differences.
双特异性酪氨酸磷酸化和调节激酶(DYRK)蛋白激酶家族是一组进化上保守的蛋白激酶,在哺乳动物、果蝇和低等真核生物中被表征为生长和发育的调节因子。在本研究中,我们鉴定了DYRK1B的三种剪接变体(DYRK1B-p65、DYRK1B-p69和DYRK1B-p75),它们具有不同的表达模式和酶活性。DYRK1B-p65和DYRK1B-p69在小鼠组织中表现出相似但不完全相同的表达模式,在脾脏、肺、脑、膀胱、胃和睾丸中蛋白质水平最高。相比之下,DYRK1B-p75在骨骼肌、神经元细胞系GT1-7以及分化的脂肪细胞样3T3-L1细胞中特异性检测到,但在未分化的3T3-L1前脂肪细胞中未检测到。对小鼠和人类Dyrk1b基因组和cDNA序列的比较确定了产生DYRK1B变体的可变剪接事件。在DYRK1B-p75中,转录从外显子1B而不是外显子1A开始,产生一个新的翻译起始点,使开放阅读框延长60个密码子。这种基因结构表明可变启动子指导DYRK1B-p69和DYRK1B-p75的表达。两种剪接变体在体外均表现出激酶活性,并且在COS-7细胞中表达时含有磷酸酪氨酸。由于外显子9中3'剪接位点的差异识别,DYRK1B-p65与DYRK1B-p69的不同之处在于催化结构域内缺少40个氨基酸。DYRK1B-p65在体外缺乏激酶活性,并且不含有磷酸酪氨酸。与DYRK1B-p65相比,DYRK1B-p69和DYRK1B-p75更强烈地刺激由横纹肌肉瘤中forkhead(FKHR)依赖性葡萄糖-6-磷酸酶启动子驱动的报告基因活性,表明DYRK1B剪接变体表现出功能差异。